These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35758018)

  • 1. A Quantitative Metal-Encoded Conjugate Platform for Targeting Ligand Discovery.
    Xu Z; Huo W; Ireland T; Huang L; Ocampo T; Vegas AJ
    Bioconjug Chem; 2022 Jul; 33(7):1279-1285. PubMed ID: 35758018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The smart targeting of nanoparticles.
    Friedman AD; Claypool SE; Liu R
    Curr Pharm Des; 2013; 19(35):6315-29. PubMed ID: 23470005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
    van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules.
    Grigoletto A; Tedeschini T; Canato E; Pasut G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1689. PubMed ID: 33314717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Say no to drugs: Bioactive macromolecular therapeutics without conventional drugs.
    Rütter M; Milošević N; David A
    J Control Release; 2021 Feb; 330():1191-1207. PubMed ID: 33207257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients.
    Bhattacharjee S; Brayden DJ
    Expert Opin Drug Discov; 2021 Mar; 16(3):235-254. PubMed ID: 33108229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Origami-Enabled Engineering of Ligand-Drug Conjugates for Targeted Drug Delivery.
    Ge Z; Guo L; Wu G; Li J; Sun Y; Hou Y; Shi J; Song S; Wang L; Fan C; Lu H; Li Q
    Small; 2020 Apr; 16(16):e1904857. PubMed ID: 32191376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine: An effective tool in cancer therapy.
    Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
    Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Nanomedicine in Tumor Spheroid as an
    Roy SM; Garg V; Barman S; Ghosh C; Maity AR; Ghosh SK
    Front Bioeng Biotechnol; 2021; 9():785937. PubMed ID: 34926430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in development of nanoparticle-based therapeutics.
    Desai N
    AAPS J; 2012 Jun; 14(2):282-95. PubMed ID: 22407288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of nanomedicines for neuron targeting.
    Garcia-Chica J; D Paraiso WK; Tanabe S; Serra D; Herrero L; Casals N; Garcia J; Ariza X; Quader S; Rodriguez-Rodriguez R
    Nanomedicine (Lond); 2020 Jul; 15(16):1617-1636. PubMed ID: 32618490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo.
    Pearce AK; Fuchs AV; Fletcher NL; Thurecht KJ
    Pharm Res; 2016 Oct; 33(10):2388-99. PubMed ID: 27225496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated drug delivery.
    Arslan FB; Ozturk Atar K; Calis S
    Int J Pharm; 2021 Mar; 596():120268. PubMed ID: 33486037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery.
    Song N; Zhang J; Zhai J; Hong J; Yuan C; Liang M
    Acc Chem Res; 2021 Sep; 54(17):3313-3325. PubMed ID: 34415728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment.
    Huang X; Mu N; Ding Y; Lam HW; Yue L; Gao C; Chen T; Yuan Z; Wang R
    Acta Biomater; 2022 Jul; 147():356-365. PubMed ID: 35577046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted drugs and nanomedicine: present and future.
    Debbage P
    Curr Pharm Des; 2009; 15(2):153-72. PubMed ID: 19149610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.